We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSI
7401
DELISTED
Stage Stores Inc
SSI
$8K ﹤0.01%
+963
New +$3.73K
OILD
7402
DELISTED
ProShares UltraPro 3x Short Crude Oil ETF
OILD
$8K ﹤0.01%
711
-5,544
-89% -$78.3K
FOMX
7403
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$8K ﹤0.01%
2,427
-8,826
-78% -$28.1K
PIR
7404
DELISTED
Pier 1 Imports, Inc.
PIR
$8K ﹤0.01%
+1,313
New +$9.79K
YUMA
7405
DELISTED
Yuma Energy Inc
YUMA
$8K ﹤0.01%
2,566
+345
+16% +$1.1K
VISL
7406
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$8K ﹤0.01%
251
+39
+18% +$1.63K
PME
7407
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$8K ﹤0.01%
+6,204
New +$10.3K
ADAP
7408
DELISTED
Adaptimmune Therapeutics
ADAP
$7K ﹤0.01%
6,227
+6,157
+8,796% +$6.57K
AIRI icon
7409
Air Industries Group
AIRI
$13M
$7K ﹤0.01%
320
-200
-38% -$2.75K
AWX icon
7410
Avalon Holdings
AWX
$9.94M
$7K ﹤0.01%
+3,540
New +$7.37K
BDRY icon
7411
Breakwave Dry Bulk Shipping ETF
BDRY
$30.7M
$7K ﹤0.01%
485
-642
-57% -$11.6K
BEEM icon
7412
Beam Global
BEEM
$24.9M
$7K ﹤0.01%
1,556
+1,506
+3,012% +$7.46K
BKTI icon
7413
BK Technologies
BKTI
$292M
$7K ﹤0.01%
456
+46
+11% +$741
BTAL icon
7414
AGF US Market Neutral Anti-Beta Fund
BTAL
$299M
$7K ﹤0.01%
+323
New +$7.48K
CAPR icon
7415
Capricor Therapeutics
CAPR
$228M
$7K ﹤0.01%
5,413
+5,159
+2,031% +$10.6K
CBON icon
7416
VanEck China Bond ETF
CBON
$26.3M
$7K ﹤0.01%
319
-423
-57% -$9.29K
CCLD icon
7417
CareCloud
CCLD
$108M
$7K ﹤0.01%
1,823
-3,730
-67% -$14.7K
CRIS icon
7418
Curis
CRIS
$8.85M
$7K ﹤0.01%
11
-8
-42% -$5.8K
DALI icon
7419
First Trust DorseyWright DALI 1 ETF
DALI
$100M
$7K ﹤0.01%
319
-1,407
-82% -$28.6K
DLHC icon
7420
DLH Holdings
DLHC
$70.1M
$7K ﹤0.01%
+1,711
New +$7.17K
EFOI icon
7421
Energy Focus
EFOI
$19.8M
$7K ﹤0.01%
435
+2
+0.5% +$31
EMX
7422
DELISTED
EMX Royalty
EMX
$7K ﹤0.01%
4,160
+913
+28% +$1.3K
FGNX
7423
FG Nexus Inc
FGNX
$44.9M
$7K ﹤0.01%
10
-18
-64% -$10.8K
FLIN icon
7424
Franklin FTSE India ETF
FLIN
$2.68B
$7K ﹤0.01%
319
+318
+31,800% +$7.17K
FPAY
7425
DELISTED
FlexShopper
FPAY
$7K ﹤0.01%
+2,831
New +$4.9K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.